NYSE$ZBH
Zimmer Biomet Holdings Inc · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Reported net sales increase of 1.0% and 6.0% on a constant currency basis and adjusted diluted earnings per share from continuing operations of $1.82.
Zimmer Biomet's Q2 2022 performance exceeded internal expectations due to a stronger COVID recovery and effective execution. Net sales reached $1.782 billion, a 1.0% increase, and adjusted diluted EPS was $1.82. The company updated its 2022 financial guidance, raising the full-year outlook.
- Second quarter net sales from continuing operations of $1.782 billion increased 1.0% and 6.0% on a constant currency basis.
- Second quarter diluted earnings per share from continuing operations were $0.73; adjusted diluted earnings per share from continuing operations were $1.82.
- Company updates 2022 financial guidance, raising range for full year outlook
- Launched new artificial intelligence (AI) capabilities within Omni™ Suite
Headline financials
Revenue & EPS history
Zimmer Biomet · Revenue · Quarterly
$1.78B
Revenue by segment
Zimmer Biomet · $1.64B total across 3 segments · Q2 2022
- Knees Net Sales$705M+5.9%43.0%
- Hips Net Sales$487M+2.7%29.7%
- S.E.T. Net Sales$446M-3.4%27.2%
Forward guidance
The Company is updating its full-year 2022 financial guidance to raise its previous projected ranges for revenue growth, foreign currency exchange impact, adjusted operating profit margin and adjusted diluted EPS from continuing operations
Tailwinds
- raising range for full year outlook
- 2022 Reported Revenue Change (1.0)% - 1.0%
- Adjusted Operating Profit Margin 26.75% - 27.75%
- Adjusted Tax Rate 16.0% - 16.5%
- Adjusted Diluted EPS from Continuing Operations $6.70 - $6.90
Headwinds
- Foreign Currency Exchange Impact (5.0)%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2022
-0.4%
Avg return
Earnings day
-1.7%
Avg return
5 days after
-2.3%
Avg return
30 days after
42%
30 / 72 earnings
Positive
+11.9%
Q3 2020
Best reaction
-15.3%
Q3 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.1% | -10.5% | -11.5% | |
| Q4 2025 | +1.9% | +7.5% | +3.2% | |
| Q3 2025 | -15.2% | -14.0% | -8.6% | |
| Q1 2025 | -11.6% | -7.0% | -10.7% | |
| Q4 2024 | -5.1% | -8.6% | -0.2% | |
| Q3 2024 | +2.9% | +4.4% | +7.9% | |
| Q2 2024 | -0.8% | -2.3% | -4.3% | |
| Q1 2024 | +1.8% | +1.6% | -3.7% | |
| Q4 2023 | -3.7% | -3.4% | -0.6% | |
| Q3 2023 | -4.1% | -3.5% | +7.3% | |
| Q2 2023 | -7.1% | -8.6% | -13.8% | |
| Q1 2023 | +0.6% | -0.7% | -8.3% | |
| Q4 2022 | +0.9% | +2.6% | -0.9% | |
| Q3 2022 | -5.7% | -3.9% | +10.0% | |
| Q2 2022 | +5.3% | +3.2% | -2.7% | |
| Q1 2022 | +4.7% | -0.3% | +1.2% | |
| Q4 2021 | -2.4% | -5.4% | -1.4% | |
| Q3 2021 | -4.8% | -9.7% | -18.5% | |
| Q2 2021 | -9.1% | -8.6% | -8.5% | |
| Q1 2021 | -2.5% | -3.1% | -10.1% | |
| Q4 2020 | -0.6% | -0.2% | -1.4% | |
| Q3 2020 | +11.9% | +7.2% | +7.0% | |
| Q2 2020 | -1.5% | +2.7% | +3.5% | |
| Q1 2020 | -6.8% | -7.8% | +10.2% | |
| Q4 2019 | +6.2% | +5.3% | -13.0% | |
| Q3 2019 | +4.9% | +5.5% | +8.1% | |
| Q2 2019 | +8.6% | +9.1% | +7.9% | |
| Q1 2019 | -3.1% | -2.8% | -8.2% | |
| Q4 2018 | +7.8% | +7.9% | +14.5% | |
| Q3 2018 | -5.6% | -7.0% | -7.7% | |
| Q2 2018 | +8.0% | +7.1% | +7.1% | |
| Q1 2018 | +5.7% | +5.8% | +0.4% | |
| Q4 2017 | -0.2% | -1.3% | -10.9% | |
| Q3 2017 | -7.7% | -10.1% | -5.8% | |
| Q2 2017 | -3.8% | -6.5% | -12.1% | |
| Q1 2017 | -4.5% | -3.7% | -4.9% | |
| Q4 2016 | +2.7% | +2.4% | +2.3% | |
| Q3 2016 | -15.3% | -15.9% | -16.9% | |
| Q2 2016 | +6.9% | +6.4% | +5.6% | |
| Q1 2016 | -0.1% | — | — | |
| Q4 2015 | -2.3% | — | — | |
| Q3 2015 | +6.8% | — | — | |
| Q2 2015 | -2.7% | — | — | |
| Q1 2015 | -4.3% | — | — | |
| Q4 2014 | -2.1% | — | — | |
| Q3 2014 | +5.1% | — | — | |
| Q2 2014 | -2.3% | — | — | |
| Q1 2014 | +9.9% | — | — | |
| Q4 2013 | +0.8% | — | — | |
| Q3 2013 | -3.3% | — | — | |
| Q2 2013 | +0.5% | — | — | |
| Q1 2013 | +0.6% | — | — | |
| Q4 2012 | -1.3% | — | — | |
| Q3 2012 | +2.0% | — | — | |
| Q2 2012 | -3.5% | — | — | |
| Q1 2012 | -0.6% | — | — | |
| Q4 2011 | -1.3% | — | — | |
| Q3 2011 | +3.7% | — | — | |
| Q2 2011 | -5.6% | — | — | |
| Q1 2011 | +0.5% | — | — | |
| Q4 2010 | +2.2% | — | — | |
| Q3 2010 | +3.6% | — | — | |
| Q2 2010 | -1.5% | — | — | |
| Q1 2009 | -0.8% | — | — | |
| Q1 2010 | +1.6% | — | — | |
| Q4 2009 | -0.2% | — | — | |
| Q3 2009 | +4.0% | — | — | |
| Q3 2008 | +4.0% | — | — | |
| Q4 2007 | -1.0% | — | — | |
| Q2 2008 | -1.0% | — | — | |
| Q2 2009 | -1.0% | — | — | |
| Q4 2008 | -1.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro